[Salpingectomy in ovarian cancer prevention: Evidence behind the hypothesis and surgical implications]. / Salpingectomía como opción de reducción de riesgo de cáncer de ovario.

Background: Over the last decade, evidence suggests the fallopian tubes are the origin of most of the high grade ovarian serous carcinomas. This type of carcinoma represents at least 50% of all the cases of epithelial ovarian cancer. Salpingectomy may lower the risk of high grade serous carcinoma. Removing the two fallopian tubes should be considered a strategy for risk reduction in patients who decide tubal sterilization or in patients with hysterectomy for benign disease. There are ongoing protocols that evaluate the ovarian hormonal production impact after prophilactic salpingectomy. In patients with BRCA1 and BRCA2 mutations, salpingo-oophorectomy is recommended usually between 35 to 40 years of age for BRCA 1 and between 40 and 45 years of age for BRCA 2. The oopherectomy done whithin these decades has the consequences and side effects of premature menopause, some physicians have suggested doing a two step procedure: perform a salpingectomy as soon as the patient has decided to have permanent birth control, and doing the ophoorectomy at the onset of menopause. The oncological safety of this approach is still under evaluation and is not recommended outside a protocol.

[Symptomatic diaphragmatic endometriosis. Laparoscopic treatment with laser CO2. Report of cases]. / Endometriosis diafragmática sintomática. Tratamiento laparoscópico con láser CO2. Informe de casos.

The endometriosis has been observed in 10% of the women in reproductive age and it is found in pelvis in most of the cases. However, occasionally it is located on nonpelvic organs and infrequently in diaphragmatic location. Two cases of diaphragmatic endometriosis with symptoms are presented and treated with CO2 laser successful. There are a few reports of laparoscopic treatment of diaphragmatic endometriosis. The patients with clinical diagnosis of endometriosis and nonpelvic symptoms have the possibility of the disease in nonpelvic organs. The adequate treatment will be in benefit of the patient.

[Hypertrophic cardiomyopathy and pregnancy. Presentation of a case and review of the literature]. / Cardiomiopatía hipertrófica y embarazo. Presentación de un caso y revisión de la literatura.

We present the case of a 31 year old woman with primary hypertrophic myocardiopathy associated with term pregnancy seen in the Department of Gynecology and Obstetrics at the Hospital ABC. Pregnancy, labor and delivery coursed without obstetric and perinatal complications. We comment the classification, etiology, diagnosis and treatment of this cardiopathy that has been reported in pregnancy in few publications.